Celularity Inc.: insider trading
130 trades by 25 directors, officers and 10% owners since 2021, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$0
0 sales by 0 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Too few open-market trades to chart.
Insiders (25)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| John R. HainesSenior Exec Vice President | 30,179 | — | — | |
| Robert J. HaririChief Executive Officer, Director | 2.85 M | — | — | |
| Stephen BrigidoPres., Functional Regeneration | 9,474 | — | — | |
| Diane L. ParksDirector | 520,021 | — | — | |
| Geoffrey LingDirector | 256,026 | — | — | |
| Peter DiamandisDirector | 394,150 | — | — | |
| Vincent LeVienDirector | 153,847 | — | — | |
| David C. BeersChief Financial Officer | 18,201 | — | — | |
| Berhad Genting10% owner | — | — | — | |
| Dean C. KehlerDirector | 303,482 | — | — | |
| Richard J. BermanDirector | 67,416 | — | — | |
| Kyle FletcherSee Remarks | 21,085 | — | — | |
| Adrian KilcoyneChief Medical Officer | 1.12 M | — | — | |
| Sorrento Therapeutics, Inc.10% owner | 5.05 M | — | — | |
| Andrew C. Von EschenbachDirector | 336,066 | — | — | |
| John SculleyDirector | 1.00 M | — | — | |
| Kok Thay LimDirector | 225,222 | — | — | |
| Marc MazurDirector | 236,066 | — | — | |
| Robin L. SmithDirector | 236,066 | — | — | |
| Bradley GloverSee Remarks | 351,192 | — | — | |
| Anne JonesChief Business Officer | 49,154 | — | — | |
| Keary DunnSee Remarks | 16,405 | — | — | |
| Starr International Co Inc10% owner | — | — | — | |
| GX Sponsor LLC10% owner | 100,000 | — | — | |
| Jay R. BloomDirector | — | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Stephen BrigidoPres., Functional Regeneration | Option exercise | +821 | — | — | 9,742 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Option exercise | +3,281 | — | — | 2.85 M | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Option exercise | +1,641 | — | — | 30,762 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Shares withheld for tax | -1,182 | $1.280 | $2 K | 2.85 M | Form 4 |
| filed | Stephen BrigidoPres., Functional Regeneration | Shares withheld for tax | -268 | $1.280 | $343 | 9,474 | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Shares withheld for tax | -583 | $1.280 | $746 | 30,179 | Form 4 |
| filed | Geoffrey LingDirector | Grant or awardamended | +19,231 | — | — | 256,026 | Form 4/A |
| filed | Vincent LeVienDirector | Grant or awardamended | +28,847 | — | — | 153,847 | Form 4/A |
| filed | Diane L. ParksDirector | Grant or awardamended | +30,000 | — | — | 520,021 | Form 4/A |
| filed | Peter DiamandisDirector | Grant or awardamended | +20,385 | — | — | 394,150 | Form 4/A |
| filed | Diane L. ParksDirector | Grant or award | +30,000 | — | — | 520,021 | Form 4 |
| filed | Vincent LeVienDirector | Grant or award | +28,847 | — | — | 153,847 | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +20,385 | — | — | 394,150 | Form 4 |
| filed | Geoffrey LingDirector | Grant or award | +19,231 | — | — | 256,026 | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +125,000 | — | — | 373,765 | Form 4 |
| filed | Geoffrey LingDirector | Grant or award | +125,000 | — | — | 236,795 | Form 4 |
| filed | Vincent LeVienDirector | Grant or award | +125,000 | — | — | 125,000 | Form 4 |
| filed | Diane L. ParksDirector | Grant or award | +125,000 | — | — | 490,021 | Form 4 |
| filed | Geoffrey LingDirector | Grant or award | +67,416 | — | — | 111,795 | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +67,416 | — | — | 248,765 | Form 4 |
| filed | Diane L. ParksDirector | Grant or award | +67,416 | — | — | 365,021 | Form 4 |
| filed | Vincent LeVienDirector | Grant or award | +3,699 | — | — | 3,699 | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +47,042 | — | — | 248,765 | Form 4 |
| filed | Diane L. ParksDirector | Grant or award | +61,539 | — | — | 365,021 | Form 4 |
| filed | Geoffrey LingDirector | Grant or award | +44,379 | — | — | 111,795 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Option exerciseamended | +3,281 | — | — | 2.85 M | Form 4/A |
| filed | Robert J. HaririChief Executive Officer, Director | Shares withheld for taxamended | -1,154 | $1.640 | $2 K | 2.85 M | Form 4/A |
| filed | Robert J. HaririChief Executive Officer, Director | Option exercise | +3,281 | — | — | 21,482 | Form 4 |
| filed | David C. BeersChief Financial Officer | Option exercise | +1,025 | — | — | 18,561 | Form 4 |
| filed | Stephen BrigidoPres., Functional Regeneration | Option exercise | +820 | — | — | 9,189 | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Option exercise | +1,641 | — | — | 29,698 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Shares withheld for tax | -1,154 | $1.640 | $2 K | 20,328 | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Shares withheld for tax | -577 | $1.640 | $946 | 29,121 | Form 4 |
| filed | Stephen BrigidoPres., Functional Regeneration | Shares withheld for tax | -268 | $1.640 | $440 | 8,921 | Form 4 |
| filed | David C. BeersChief Financial Officer | Shares withheld for tax | -360 | $1.640 | $590 | 18,201 | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Option exercise | +20,000 | — | — | 35,092 | Form 4 |
| filed | Stephen BrigidoPres., Functional Regeneration | Option exercise | +10,000 | — | — | 11,641 | Form 4 |
| filed | David C. BeersChief Financial Officer | Option exercise | +12,500 | — | — | 21,932 | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Shares withheld for tax | -7,035 | $2.140 | $15 K | 28,057 | Form 4 |
| filed | David C. BeersChief Financial Officer | Shares withheld for tax | -4,396 | $2.140 | $9 K | 17,536 | Form 4 |
| filed | Stephen BrigidoPres., Functional Regeneration | Shares withheld for tax | -3,272 | $2.140 | $7 K | 8,369 | Form 4 |
| filed | Berhad Genting10% owner | Exercise of in-the-money derivativeindirect | +535,274 | $2.070 | $1.1 M | 5.68 M | Form 4 |
| filed | Berhad Genting10% owner | Exercise of in-the-money derivativeindirect | +652,981 | $2.070 | $1.4 M | 6.34 M | Form 4 |
| filed | Peter DiamandisDirector | Grant or awardamended | +67,416 | — | — | 201,723 | Form 4/A |
| filed | Diane L. ParksDirector | Grant or award | +67,416 | — | — | 303,482 | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +67,416 | — | — | 1.37 M | Form 4 |
| filed | Geoffrey LingDirector | Grant or award | +67,416 | — | — | 67,416 | Form 4 |
| filed | Richard J. BermanDirector | Grant or award | +67,416 | — | — | 67,416 | Form 4 |
| filed | Dean C. KehlerDirector | Grant or award | +67,416 | — | — | 303,482 | Form 4 |
| filed | David C. BeersChief Financial Officer | Shares withheld for tax | -360 | $4.110 | $1 K | 23,983 | Form 4 |
| filed | John R. HainesSee Remarks | Shares withheld for tax | -576 | $4.110 | $2 K | 38,373 | Form 4 |
| filed | Stephen BrigidoPres, Functional Regeneration | Shares withheld for tax | -268 | $4.110 | $1 K | 19,472 | Form 4 |
| filed | Robert J. HaririChief Executive Officer | Shares withheld for tax | -1,154 | $4.110 | $5 K | 2.86 M | Form 4 |
| filed | Kyle FletcherSee Remarks | Shares withheld for tax | -20 | $4.110 | $82 | 21,085 | Form 4 |
| filed | Kyle FletcherSee Remarks | Shares withheld for tax | -617 | $5.680 | $4 K | 21,105 | Form 4 |
| filed | Stephen BrigidoPres, Functional Regeneration | Shares withheld for tax | -32,720 | $0.430 | $14 K | 197,406 | Form 4 |
| filed | Adrian KilcoyneChief Medical Officer | Shares withheld for tax | -52,762 | $0.430 | $23 K | 1.12 M | Form 4 |
| filed | John R. HainesSee Remarks | Shares withheld for tax | -70,350 | $0.430 | $30 K | 389,497 | Form 4 |
| filed | David C. BeersChief Financial Officer | Shares withheld for tax | -43,968 | $0.430 | $19 K | 243,437 | Form 4 |
| filed | Kyle FletcherSee Remarks | Shares withheld for tax | -39,571 | $0.430 | $17 K | 217,228 | Form 4 |
| filed | Berhad Genting10% owner | Buyindirect | +21.41 M | $0.250 | $5.4 M | 51.47 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Buy | +6.31 M | $0.160 | $1.0 M | 25.52 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Buy | +3.05 M | $0.160 | $488 K | 28.57 M | Form 4 |
| filed | Sorrento Therapeutics, Inc.10% owner | Sell | -6.31 M | — | — | 5.05 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Buy | +9.06 M | $0.170 | $1.5 M | 19.21 M | Form 4 |
| filed | Sorrento Therapeutics, Inc.10% owner | Sell | -9.06 M | — | — | 11.36 M | Form 4 |
| filed | Adrian KilcoyneChief Medical Officer | Grant or award | +875,000 | — | — | 1.18 M | Form 4 |
| filed | Kok Thay LimDirector | Shares withheld for taxamended | -10,844 | $0.750 | $8 K | 225,222 | Form 4/A |
| filed | Kok Thay LimDirector | Grant or award | +199,921 | — | — | 236,066 | Form 4 |
| filed | Robin L. SmithDirector | Grant or award | +199,921 | — | — | 236,066 | Form 4 |
| filed | Diane L. ParksDirector | Grant or award | +199,921 | — | — | 236,066 | Form 4 |
| filed | Dean C. KehlerDirector | Grant or award | +199,921 | — | — | 236,066 | Form 4 |
| filed | Andrew C. Von EschenbachDirector | Grant or award | +199,921 | — | — | 336,066 | Form 4 |
| filed | Marc MazurDirector | Grant or award | +199,921 | — | — | 236,066 | Form 4 |
| filed | John SculleyDirector | Grant or award | +199,921 | — | — | 1.00 M | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +199,921 | — | — | 1.31 M | Form 4 |
| filed | Bradley GloverSee Remarks | Shares withheld for tax | -2,884 | $0.710 | $2 K | 351,192 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Shares withheld for tax | -11,540 | $0.710 | $8 K | 10.15 M | Form 4 |
| filed | Kyle FletcherSee Remarks | Shares withheld for tax | -201 | $0.710 | $143 | 256,799 | Form 4 |
| filed | David C. BeersChief Financial Officer | Shares withheld for tax | -3,606 | $0.710 | $3 K | 287,405 | Form 4 |
| filed | Stephen BrigidoPres, Functional Regeneration | Shares withheld for tax | -2,683 | $0.710 | $2 K | 230,126 | Form 4 |
| filed | John R. HainesSee Remarks | Shares withheld for tax | -5,770 | $0.710 | $4 K | 459,847 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Grant or award | +2.08 M | $0.830 | $1.7 M | 10.16 M | Form 4 |
| filed | Kyle FletcherSee Remarks | Shares withheld for tax | -2,170 | $0.630 | $1 K | 257,000 | Form 4 |
| filed | John R. HainesSenior Exec Vice President | Grant or award | +400,000 | — | — | 465,617 | Form 4 |
| filed | Stephen BrigidoPres, Functional Regeneration | Grant or award | +200,000 | — | — | 232,809 | Form 4 |
| filed | Kyle FletcherSee Remarks | Grant or award | +225,000 | — | — | 259,170 | Form 4 |
| filed | David C. BeersChief Financial Officer | Grant or award | +250,000 | — | — | 291,011 | Form 4 |
| filed | Adrian KilcoyneChief Medical Officer | Grant or award | +300,000 | — | — | 300,000 | Form 4 |
| filed | Bradley GloverSee Remarks | Grant or award | +300,000 | — | — | 354,076 | Form 4 |
| filed | Peter DiamandisDirector | Option exercise | +1.07 M | $0.280 | $300 K | 1.11 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Buy | +10,000 | $1.720 | $17 K | 8.07 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Buy | +40,000 | $1.710 | $68 K | 8.06 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Buy | +40,000 | $1.740 | $70 K | 8.02 M | Form 4 |
| filed | Kyle FletcherGeneral Counsel | Shares withheld for tax | -1,262 | $1.890 | $2 K | 34,170 | Form 4 |
| filed | Anne JonesChief Business Officer | Shares withheld for tax | -3,734 | $1.890 | $7 K | 49,154 | Form 4 |
| filed | John SculleyDirector | Option exercise | +768,594 | $0.280 | $215 K | 804,739 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Option exercise | +119,073 | $2.870 | $342 K | 7.98 M | Form 4 |
| filed | Peter DiamandisDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Kyle FletcherGeneral Counsel | Grant or award | +2,297 | — | — | 35,432 | Form 4 |
| filed | Andrew C. Von EschenbachDirector | Grant or award | +36,145 | — | — | 136,145 | Form 4 |
| filed | Dean C. KehlerDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Kok Thay LimDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Anne JonesChief Business Officer | Grant or award | +11,483 | — | — | 27,888 | Form 4 |
| filed | Robin L. SmithDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Bradley GloverChief Technology Officer, Director | Grant or award | +13,124 | — | — | 32,810 | Form 4 |
| filed | John SculleyDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Marc MazurDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Diane L. ParksDirector | Grant or award | +36,145 | — | — | 36,145 | Form 4 |
| filed | Keary DunnSee Remarks | Grant or award | +16,405 | — | — | 16,405 | Form 4 |
| filed | Stephen BrigidoPres, Functional Regeneration | Grant or award | +32,809 | — | — | 32,809 | Form 4 |
| filed | John R. HainesSee Remarks | Grant or award | +65,617 | — | — | 65,617 | Form 4 |
| filed | Anne JonesChief Business Officer, Director | Grant or award | +16,405 | — | — | 16,405 | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Grant or award | +131,234 | — | — | 7.87 M | Form 4 |
| filed | David C. BeersChief Financial Officer | Grant or award | +41,011 | — | — | 41,011 | Form 4 |
| filed | Bradley GloverChief Technology Officer, Director | Grant or award | +19,686 | — | — | 19,686 | Form 4 |
| filed | Starr International Co Inc10% owner | Exercise of in-the-money derivativeindirect | +6.64 M | $3.500 | $23.2 M | 15.28 M | Form 4 |
| filed | Anne JonesChief Business Officer | Grant or award | +25,000 | — | — | 52,888 | Form 4 |
| filed | Bradley GloverSee Remarks | Grant or award | +25,000 | — | — | 57,810 | Form 4 |
| filed | Bradley GloverSee Remarks | Shares withheld for tax | -3,734 | $1.890 | $7 K | 54,076 | Form 4 |
| filed | Andrew C. Von EschenbachDirector | Option exercise | +100,000 | $0.280 | $28 K | 100,000 | Form 4 |
| filed | Dean C. KehlerDirector | Conversionindirect | +7.19 M | — | — | 7.19 M | Form 4 |
| filed | GX Sponsor LLC10% owner | Conversion | +7.19 M | — | — | 7.19 M | Form 4 |
| filed | Robert J. HaririChief Executive Officer, Director | Other | +7.73 M | — | — | 7.73 M | Form 4 |
| filed | Jay R. BloomDirector | Conversionindirect | +7.19 M | — | — | 7.19 M | Form 4 |
| filed | Kok Thay LimDirector, 10% owner | Grant or awardindirect | +26.56 M | — | — | 26.56 M | Form 4 |
| filed | Jay R. BloomDirector | Otherindirect | -7.09 M | — | — | 100,000 | Form 4 |
| filed | Dean C. KehlerDirector | Otherindirect | -7.09 M | — | — | 100,000 | Form 4 |
| filed | GX Sponsor LLC10% owner | Other | -7.09 M | — | — | 100,000 | Form 4 |
| filed | Kok Thay LimDirector, 10% owner | Grant or awardindirect | +3.50 M | $10.00 | $35.0 M | 30.06 M | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice